Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (60 ops.)
Latest filing published 17 Feb 2026 for Enliven Therapeutics, Inc..
Filing timeline
BuySaleJoseph P. Lyssikatos
Insider track record
Disclosed buys
0
Disclosed sells
60
Signal history
Joseph P. Lyssikatos: trading record in brief
Sixty open-market sales out of 75 filings: Joseph P. Lyssikatos almost always sells, for EUR 10.4 million in total and a median of EUR 98,234, with no purchase. The largest are dated January 9, 2026 (EUR 1,249,371 and EUR 879,947) and October 9, 2024 (EUR 881,092), all at Enliven Therapeutics, Inc.
The record runs from February 27, 2023 to February 17, 2026, with the title "CHIEF SCIENTIFIC OFFICER". It includes 13 option exercises and 2 grants. The annual peak is 2024 with 34 filings, ahead of 2025 (20) and 2023 (13). The last 12 months hold 11 filings, 10 of them sales.
Trades by Joseph P. Lyssikatos often coincide with those of colleagues at Enliven Therapeutics, Inc.: 56 fall within 30 days of a trade by Anish Patel, 52 for Samuel Kintz, 49 for Benjamin Hohl 39 for Richard A. Heyman and 17 for Helen Louise Collins, all in the same direction.
Companies and markets linked to Joseph P. Lyssikatos
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations75 total
18,750 shares0Common StockSEC:0001967150-26-000004:0
5,000 shares@ US$29.04383.3% of flowCommon StockSEC:0001967150-26-000003:0
14,509 shares@ US$26.903.2% of flowCommon StockSEC:0001967150-26-000002:1
5,491 shares@ US$26.3733.3% of flowCommon StockSEC:0001967150-26-000002:0
33,802 shares@ US$24.926.8% of flowCommon StockSEC:0001967150-26-000001:1
41,198 shares@ US$24.908.3% of flowCommon StockSEC:0001967150-26-000001:2
50,000 shares@ US$29.1311.8% of flowCommon StockSEC:0001967150-26-000001:3
7,500 shares@ US$20.12823.4% of flowCommon StockSEC:0001967150-26-000001:0
5,000 shares@ US$16.84121.9% of flowCommon StockSEC:0001967150-25-000008:0
492 shares@ US$23.090.1% of flowCommon StockSEC:0001967150-25-000007:1
12,008 shares@ US$22.30136.1% of flowCommon StockSEC:0001967150-25-000007:0
12,500 shares@ US$22.0826.3% of flowCommon StockSEC:0001967150-25-000006:0
4,000 shares@ US$20.25131.8% of flowCommon StockSEC:0001967150-25-000005:0
1,500 shares@ US$20.030.7% of flowCommon StockSEC:0001967150-25-000004:0
2,130 shares@ US$20.020.3% of flowCommon StockSEC:0001967150-25-000003:1
4,870 shares@ US$19.10952.1% of flowCommon StockSEC:0001967150-25-000003:0
7,500 shares@ US$20.011.2% of flowCommon StockSEC:0001415889-25-022648:1
5,000 shares@ US$19.62352.2% of flowCommon StockSEC:0001415889-25-022648:0
576 shares@ US$22.900.1% of flowCommon StockSEC:0001415889-25-020206:1
11,924 shares@ US$22.26256.0% of flowCommon StockSEC:0001415889-25-020206:0
12,500 shares@ US$21.39666.1% of flowCommon StockSEC:0001415889-25-018116:0
7,500 shares@ US$20.02933.5% of flowCommon StockSEC:0001415889-25-015787:0
5,000 shares@ US$16.30671.9% of flowCommon StockSEC:0001415889-25-013993:0
2,470 shares@ US$20.010.4% of flowCommon StockSEC:0001415889-25-012031:1
5,030 shares@ US$20.07282.4% of flowCommon StockSEC:0001415889-25-012031:0
25 of 75 declarations
